Premium
Botulinum toxin A as monotherapy for syringoma
Author(s) -
ZaldivarFujigaki José Luis,
Achell Nava Lucia
Publication year - 2021
Publication title -
journal of cosmetic dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.626
H-Index - 44
eISSN - 1473-2165
pISSN - 1473-2130
DOI - 10.1111/jocd.13919
Subject(s) - botulinum toxin , syringoma , dermatology , toxin , medicine , pharmacology , microbiology and biotechnology , surgery , biology
Syringoma is a benign adnexal tumor of the skin originating from the eccrine sweat duct. There is a wide variety of treatments, and most of the patients receive multiple unsuccessful therapies. The goal of this report intends to describe a novel technique applicable to syringoma with botulinum toxin A. A 61‐year‐old female patient with localized syringomas in the periocular and upper lip region, with a long‐lasting history, treated with botulinum toxin A 46 IU as monotherapy intradermally distributed and a follow‐up for 8 months. Our patient displayed a significant improvement of the syringomas. Botulinum toxin A is an efficient and safe technique to treat syringomas.